FORM by GBY review
Flat, all-inclusive compounded pricing plus a real path to FDA-approved Wegovy — but no stated turnaround time, and state coverage is only documented for a handful of states, both real planning gaps for a working parent.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
FORM by GBY at a glance
- Semaglutide
- $299/mo
- Tirzepatide
- $399/mo
- Coverage
- CA, MA, VT confirmed (RI pending); other states not disclosed
- Start
- Not disclosed
How we scored FORM by GBY
Each factor is scored from FORM by GBY's real pricing, disclosures and intake flow, then combined into the 53/100 Rx-Readiness Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Not disclosed anywhere on the site.
Compounded pricing is flat and all-inclusive; the separate Wegovy membership doesn't itemize drug cost.
Not stated either way in the visible copy.
Only CA, MA, VT confirmed for one named clinician; no company-wide list.
Both molecules, though pricing on one isn't cleanly posted.
Site describes no long-term commitment; no detailed written cancellation policy found.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- www.formbygby.com/semaglutide
Verified directly against formbygby.com 2026-08-04 (owner-named, parent brand GBY Beauty). Compounded semaglutide $299/mo and tirzepatide $399/mo both stated all-inclusive. A separate Wegovy® membership is $95/mo with the drug's own cost not clearly itemized. State coverage is not company-wide published; only a telehealth-consent document naming one clinician's individual licenses (CA, MA, VT; RI pending) gives any concrete figure. No stated time-to-first-dose or intake format.
What to expect when you sign up
We walked FORM by GBY's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1Parent brand is GBY Beauty; FORM is its telehealth line for GLP-1, peptides, hair, and longevity
- 2Dedicated /semaglutide, /tirzepatide, /wegovy, and /zepbound pages each post a price
- 3A telehealth consent document names the clinical director's individual state licenses — California, Massachusetts, Vermont, Rhode Island pending
What we noticed
- No stated time-to-first-dose anywhere on the site
- The compounded pages ($299/$399) read as genuinely all-inclusive
- The separate $95/mo Wegovy membership doesn't clearly itemize the drug's own cost — flagged, not headlined
- State coverage is only documented for one named clinician's licenses, not published as a company-wide list
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $299 | InjectionSite states 'transparent, all-inclusive pricing.' |
| Compounded tirzepatide | $399 | InjectionSame all-inclusive structure. |
| Brand semaglutide | $95 | Wegovy® membershipA $95/mo membership for FDA-approved Wegovy — the drug's own cost isn't clearly itemized as included, so don't read $95 as the all-in price. |
Swipe the table to see plan details →
HSA/FSA is commonly accepted for GLP-1 telehealth — check your plan. Prices reflect FORM by GBY's public disclosures at last review and change often; confirm the current number on FORM by GBY's own site.
What we like
- Compounded semaglutide and tirzepatide both clearly all-inclusive at $299/$399
- A real path to FDA-approved Wegovy®, not compounded-only
- Dedicated pages per drug, not one vague weight-loss catch-all
The caveats
- No stated time-to-first-dose anywhere on the site
- The $95/mo Wegovy membership doesn't clearly itemize whether the drug's cost is included
- No company-wide state list — only three states named for one clinician
- No named compounding pharmacy
FORM by GBY for working moms: our verdict
Flat, all-inclusive compounded pricing plus a real path to FDA-approved Wegovy — but no stated turnaround time, and state coverage is only documented for a handful of states, both real planning gaps for a working parent. It runs about $299/month, flat across every dose — a premium to the category, so the extras have to earn it.
We weigh FORM by GBY the way working moms actually have to: not just the monthly line on your budget, but how fast you can start without a scheduled video visit and a flat monthly price that doesn't climb as your dose does — the parts a generic weight-loss review skips.
What FORM by GBY actually costs
- Compounded semaglutide — Injection: $299/mo
- Compounded tirzepatide — Injection: $399/mo
- Brand-name semaglutide — Wegovy® membership: $95/mo
For context, the typical ongoing price across our roster is around $175/month, so FORM by GBY sits at the premium end.
The medications FORM by GBY prescribes
FORM by GBY prescribes semaglutide and tirzepatide — the two molecules with the strongest published weight-loss outcomes, and having both on one account matters because you can switch between them without re-enrolling or hunting for a new provider mid-plan. It can route you to FDA-approved brand pens as well as compounded versions — the on-label products carry the manufacturer's own labeling, though the brand price runs well above the compounded tiers.
Where FORM by GBY fits — and where it doesn't — for working moms
A good fit if…
- you want a flat price that doesn't climb every time you titrate up a dose.
Look elsewhere if…
- you'd rather the most predictable place to start and pause — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and the fine print
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing working moms can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
One line that applies to every provider on this site: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
FORM by GBY is a reasonable option — weigh it on how fast you can start without a scheduled video visit and a flat monthly price that doesn't climb as your dose does against the alternatives below. For most working moms, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for working moms
Best for: A working parent who wants the option of a brand-name pen alongside compounded semaglutide/tirzepatide, and who will confirm turnaround time and state coverage directly before counting on either.
Alternatives to FORM by GBY
Providers we have a referral relationship with, ordered by Rx-Readiness Score — highest first. A fee never moves a score, but it does decide who appears here, so this is not the full list: see the complete ranking.
- Visit CoreAge RxRx-Readiness95100CoreAge RxOur #1 pick
The shortlist pick: one flat price that doesn't climb as your dose does, both molecules on a single plan, and a nationwide async intake you can finish on a break.
- Visit Trimi HealthRx-Readiness88100
The price-first partner: some of the lowest flat, all-inclusive compounded pricing we track, nationwide and async — strong if the monthly number is your deciding factor and you read the annual-prepay fine print.
- Visit Telos RxRx-Readiness86100
A fast, fully async start with a needle-free sublingual tirzepatide option and — a genuine upgrade since our last check — flat pricing stated in writing. The catch is a state list it still won't publish.
Keep comparing FORM by GBY
Head-to-head & alternatives
FORM by GBY, answered
- How fast can I get a first dose from FORM by GBY?
- Not stated on the site — there's no published turnaround time for either the compounded or brand-name path.
- Is FORM by GBY available nationwide?
- No company-wide list is published. The only concrete figures name three states (CA, MA, VT; RI pending) for one clinician — don't assume broader coverage without asking directly.
Pricing, states and verification reflect FORM by GBY's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.